Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ·Healthcare·Biotechnology
$21.34
-3.18%
Mkt Cap $1.55B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (6 analysts)
$35.00
Range $35.00 – $35.00
Implied Upside
+64.0%
Consensus $35.00 vs current $21.34
NASDAQ·Healthcare·Biotechnology
$21.34
-3.18%
Mkt Cap $1.55B
Buy
4
Hold
0
Sell
0
Price Target (6 analysts)
$35.00
Range $35.00 – $35.00
+64.0%
Consensus $35.00 vs current $21.34